Aspect Medical Systems, Inc. (NASDAQ: ASPM) announced that study results from the BRITE (Biomarkers for Rapid Identification of Treatment Effectiveness) trial in major depression demonstrate that the company’s EEG-based Antidepressant Treatment Response (ATR) indicator is a significant predictor of patient response and remission from depression when utilized one week following initiation of treatment with escitalopram. [click link for full article]
Popularity: 1% [?]
Related posts:
- Aspect Medical Systems Announces Positive Results Of BRITE Major Depression National Study
- Aspect Medical Systems Presents Positive Results Of BRITE Major Depression Study At Scientific Conferences
- Forest Laboratories, Inc. Announces Positive Results Of LEXAPRO(R) Phase III Study In Adolescents With Major Depression
- Targacept Announces Positive Results Of Phase II Clinical Trial In Major Depression
- Effects Of Depression And Pain Severity On Satisfaction In Medical Outpatients: Analysis Of The Medical Outcomes Study
Comments
No Responses to “Aspect Medical Systems Announces Positive Results Of BRITE Major Depression National Study”